13F-HR filed by Commodore Capital LP
Commodore Capital LP filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 21:17:52 UTC, with 37 holding rows worth $1,290,641,676.
- Accession
- 0001831942-26-000052
- Filer
- CIK 1831942
- Filed
- 2026-11-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
13F report for Q3 2026
A holdings report, 37 entries on the cover page, a total value of $1,290,641,676 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,290,641,676 with VALUE read as dollars as filed, 13F file number 028-20976. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 12,000,000 | $216,600,000 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 3,275,000 | $150,126,000 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 2,875,360 | $116,509,587 | dollars as filed | |
| ALTO NEUROSCIENCE INC COM SHS | 02157Q109 | Stock | 2,723,196 | $69,523,194 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 700,000 | $62,321,000 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 2,000,000 | $58,200,000 | dollars as filed | |
| LB PHARMACEUTICALS INC | 50180M108 | COMMON STOCK | 1,282,273 | $49,213,638 | dollars as filed | |
| DAMORA THERAPEUTICS INC | G2646Y104 | COMM STK | 1,939,000 | $41,261,920 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 1,265,000 | $40,505,300 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 1,725,000 | $37,725,750 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 1,000,000 | $32,410,000 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 925,000 | $29,341,000 | dollars as filed | |
| SURROZEN INC | 86889P208 | COMMON STOCK | 885,000 | $28,479,300 | dollars as filed | |
| KORSANA BIOSCIENCES INC | 23255M303 | COMMON STOCK | 877,022 | $28,064,704 | dollars as filed | |
| SAGIMET BIOSCIENCES INC A | 786700104 | COMMON STOCK | 2,757,742 | $27,246,491 | dollars as filed | |
| DEFINIUM THERAPEUTICS INC | 24477V105 | COM SHS | 700,000 | $26,642,000 | dollars as filed | |
| ADARx Pharmaceuticals, Inc. | 00654F105 | Common Stock, par value $0.0001 per share | 1,260,577 | $25,135,905 | dollars as filed | |
| EDITAS MEDICINE INC | 28106W103 | COM | 8,889,000 | $22,844,730 | dollars as filed | |
| ENTERA BIO LTD | M40527109 | SHS | 7,352,941 | $21,397,058 | dollars as filed | |
| ATTOVIA THERAPEUTICS INC | 04987L102 | COM | 1,160,000 | $19,882,400 | dollars as filed | |
| AGENUS INC | 00847G804 | COM NEW | 1,985,387 | $19,714,893 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 175,000 | $19,563,250 | dollars as filed | |
| Inflarx Nv | N44821101 | COM | 9,268,220 | $16,682,796 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 1,018,319 | $15,610,830 | dollars as filed | |
| AN2 THERAPEUTICS INC | 037326105 | COM | 2,933,680 | $15,607,178 | dollars as filed | |
| CENTURY THERAPEUTICS INC | 15673T100 | COM | 8,695,652 | $14,869,565 | dollars as filed | |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 3,250,000 | $13,520,000 | dollars as filed | |
| INHIBIKASE THERAPEUTICS INC | 45719W205 | COMMON STOCK | 5,397,488 | $11,091,838 | dollars as filed | |
| ASSEMBLY BIOSCIENCES INC | 045396207 | COMMON STOCK | 461,922 | $10,850,548 | dollars as filed | |
| PEPGEN INC COM | 713317105 | Stock | 4,475,000 | $10,829,500 | dollars as filed | |
| SAB BIOTHERAPEUTICS INC | 78397T202 | COMMON STOCK | 2,870,000 | $9,097,900 | dollars as filed | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 2,350,000 | $8,859,500 | dollars as filed | |
| RESEARCH ALLIANCE CORP IV | G75228109 | CL A ORD SHS | 500,000 | $5,785,000 | dollars as filed | |
| HELIX ACQUISITION CORP III | G4444S107 | USD CL A ORD SHS | 500,000 | $5,310,000 | dollars as filed | |
| JATT III ACQUISITION CORP | G5080G109 | COM | 400,000 | $4,408,000 | dollars as filed | |
| TCGX ACQUISITION CORP | G8708J109 | COM | 300,000 | $3,753,000 | dollars as filed | |
| LeonaBio Inc | 04746L203 | COM | 464,398 | $1,657,901 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001831942-26-000052 | this filing | 2026-11-16 |